Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. 1994

T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
Department of Medicine, Klinikum Steglitz-Free University, Berlin, Germany.

This 8-week, double-blind, multicentre study compared the efficacy and safety of the combination of quinapril and hydrochlorothiazide (HCTZ) with each drug as monotherapy. Outpatients with moderate to severe hypertension defined as supine diastolic blood pressure (DBP) > or = 105 mmHg and < or = 120 mmHg at the end of a 2 to 4-week placebo-baseline period were randomly assigned to one of the three treatments: once-daily 10 mg quinapril plus 12.5 mg HCTZ or monotherapy with these doses. After 4 weeks, the doses were to be doubled for the remaining 4 weeks. Three hundred and sixty-eight patients were randomized to double-blind medication; 346 completed the study. Seven patients withdrew due to lack of efficacy. Four patients withdrew due to side effects. In all three treatment groups, clinically significant reductions in DBP were achieved. Combination therapy was statistically more effective than each component taken as monotherapy. Adverse events were infrequent in all treatment groups. No patients experienced symptomatic hypotension or orthostatic hypotension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
July 1995, Journal of cardiovascular pharmacology,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
April 2006, Journal of human hypertension,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
July 2000, Journal of clinical pharmacology,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
December 1987, Journal of clinical hypertension,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
April 1995, Revue medicale de Liege,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
January 2008, Drugs,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
January 2012, International journal of hypertension,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
January 2009, Drugs,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
November 1990, Journal of cardiovascular pharmacology,
T Lenz, and K L Schulte, and B Wagner, and J Lilienthal, and R Gotzen
January 2001, Clinical cardiology,
Copied contents to your clipboard!